BME:LLN Statistics
Total Valuation
BME:LLN has a market cap or net worth of EUR 17.17 million. The enterprise value is 22.12 million.
| Market Cap | 17.17M |
| Enterprise Value | 22.12M |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:LLN has 15.90 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 15.90M |
| Shares Outstanding | 15.90M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.48% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 13.70.
| PE Ratio | 13.70 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 3.10 |
| P/TBV Ratio | 14.01 |
| P/FCF Ratio | 9.19 |
| P/OCF Ratio | 8.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 11.83.
| EV / Earnings | 17.64 |
| EV / Sales | 1.08 |
| EV / EBITDA | 9.52 |
| EV / EBIT | 13.52 |
| EV / FCF | 11.83 |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 1.14.
| Current Ratio | 0.76 |
| Quick Ratio | 0.76 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 3.37 |
| Interest Coverage | 8.89 |
Financial Efficiency
Return on equity (ROE) is 25.94% and return on invested capital (ROIC) is 14.06%.
| Return on Equity (ROE) | 25.94% |
| Return on Assets (ROA) | 6.03% |
| Return on Invested Capital (ROIC) | 14.06% |
| Return on Capital Employed (ROCE) | 18.81% |
| Weighted Average Cost of Capital (WACC) | 7.41% |
| Revenue Per Employee | 158,139 |
| Profits Per Employee | 9,718 |
| Employee Count | 129 |
| Asset Turnover | 1.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:LLN has paid 114,425 in taxes.
| Income Tax | 114,425 |
| Effective Tax Rate | 8.42% |
Stock Price Statistics
The stock price has decreased by -11.84% in the last 52 weeks. The beta is 0.89, so BME:LLN's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -11.84% |
| 50-Day Moving Average | 1.13 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 19,053 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:LLN had revenue of EUR 20.40 million and earned 1.25 million in profits. Earnings per share was 0.08.
| Revenue | 20.40M |
| Gross Profit | 6.02M |
| Operating Income | 1.64M |
| Pretax Income | 1.36M |
| Net Income | 1.25M |
| EBITDA | 2.32M |
| EBIT | 1.64M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 1.19 million in cash and 6.31 million in debt, with a net cash position of -5.12 million or -0.32 per share.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 6.31M |
| Net Cash | -5.12M |
| Net Cash Per Share | -0.32 |
| Equity (Book Value) | 5.54M |
| Book Value Per Share | 0.36 |
| Working Capital | -1.84M |
Cash Flow
In the last 12 months, operating cash flow was 1.91 million and capital expenditures -44,949, giving a free cash flow of 1.87 million.
| Operating Cash Flow | 1.91M |
| Capital Expenditures | -44,949 |
| Depreciation & Amortization | 688,142 |
| Net Borrowing | -908,433 |
| Free Cash Flow | 1.87M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 29.49%, with operating and profit margins of 8.02% and 6.15%.
| Gross Margin | 29.49% |
| Operating Margin | 8.02% |
| Pretax Margin | 6.66% |
| Profit Margin | 6.15% |
| EBITDA Margin | 11.39% |
| EBIT Margin | 8.02% |
| FCF Margin | 9.16% |
Dividends & Yields
BME:LLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | 7.30% |
| FCF Yield | 10.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:LLN has an Altman Z-Score of 2.71 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 5 |